AGN 3.13% 77.5¢ argenica therapeutics limited

Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007

  1. lightbulb Created with Sketch. 851
 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.